Philadelphia has taken pharmacy benefit managers (PBMs) like CVS Health, Express Scripts, and Optum to federal court, alleging they contributed significantly to the opioid crisis in the city. The lawsuit claims that these companies knowingly over-distributed opioids, deceivingly marketed them to boost profits, and profited from the addiction epidemic.
The city's complaint argues that PBMs played a critical role as intermediaries between insurers, manufacturers, and pharmacies, allowing powerful and addictive opioids to flood local communities. As such, they made the situation worse for Philadelphians. Mayor Cherelle Parker stated, "We will not sit idly by while corporations boost their bottom lines at the expense of the health and safety of Philadelphians."
According to the lawsuit, CVS Health, Express Scripts, and Optum had access to vast amounts of data on prescription patterns, insurance claims, and clinical records. Despite this, they allegedly continued to prescribe and dispense opioids in exchange for rebates from manufacturers.
CVS Health has denied these allegations, stating that the claims are "without merit" and that they will defend themselves vigorously. Express Scripts and Optum have yet to respond to requests for comment.
The lawsuit seeks compensatory and punitive damages as well as court-ordered corrective action programs to address Philadelphia's opioid epidemic. The crisis has had a devastating impact on public health, safety, and peace in the city. Fatal overdoses peaked at 1,400 in 2022, with most involving opioids and disproportionately affecting Black and Hispanic communities.
Preliminary data show that fatal overdoses have decreased by 19% from 2023 to 2024. However, the opioid crisis remains a pressing concern for Philadelphia. Pennsylvania has seized nearly 50 million fentanyl doses this year, including 27 million from the Philadelphia region.
City officials argue that holding these corporations accountable is crucial in addressing the ongoing impact of addiction on local communities. Chief Public Safety Director Adam Geer stated, "Holding those responsible who benefited from exacerbating this situation will help the city continue to right this tragic wrong."
The city's complaint argues that PBMs played a critical role as intermediaries between insurers, manufacturers, and pharmacies, allowing powerful and addictive opioids to flood local communities. As such, they made the situation worse for Philadelphians. Mayor Cherelle Parker stated, "We will not sit idly by while corporations boost their bottom lines at the expense of the health and safety of Philadelphians."
According to the lawsuit, CVS Health, Express Scripts, and Optum had access to vast amounts of data on prescription patterns, insurance claims, and clinical records. Despite this, they allegedly continued to prescribe and dispense opioids in exchange for rebates from manufacturers.
CVS Health has denied these allegations, stating that the claims are "without merit" and that they will defend themselves vigorously. Express Scripts and Optum have yet to respond to requests for comment.
The lawsuit seeks compensatory and punitive damages as well as court-ordered corrective action programs to address Philadelphia's opioid epidemic. The crisis has had a devastating impact on public health, safety, and peace in the city. Fatal overdoses peaked at 1,400 in 2022, with most involving opioids and disproportionately affecting Black and Hispanic communities.
Preliminary data show that fatal overdoses have decreased by 19% from 2023 to 2024. However, the opioid crisis remains a pressing concern for Philadelphia. Pennsylvania has seized nearly 50 million fentanyl doses this year, including 27 million from the Philadelphia region.
City officials argue that holding these corporations accountable is crucial in addressing the ongoing impact of addiction on local communities. Chief Public Safety Director Adam Geer stated, "Holding those responsible who benefited from exacerbating this situation will help the city continue to right this tragic wrong."